Leukocyte reduction filters: A source of peripheral blood leukocytes for research and drug production

Abstract

References 1. Goodnough LT, Shander A, Spence R. Bloodless medicine: Clinical care without allogeneic blood transfusion. Transfusion 2003;43:668-76. 2. Kickler TS. Blood Conservation and Transfusion Alternatives: Introduction. In: Blood Conservation and Transfusion Alternatives: Educational Satellite Symposium Syllabus of the 28th World Congress of the International Society of Hematology, Toronto, Ontario, Canada; 2000. 3. Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah’s witnesses). Ann R Coll Surg Engl 2005;87:3-14. 4. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med 1999;340:409-17. 5. Blood Flow; 24 April, 2017. Available from: https://www. timesofindia.indiatimes.com. [Last accessed on 2018 Oct 17]. 6. Schaffer A. How Jehovah’s Witness are Changing Medicine, the New Yorker; 12 August, 2015. Available from: https://www. newyorker.com/news/news-how-jehovahs-witnesses-are-changing -smedicine. [Last accessed on 2018 Oct 17]. 7. Spahn DR, Moch H, Hofmann A, Isbister JP. Patient blood management: The pragmatic solution for the problems with blood transfusions. Anesthesiology 2008;109:951-3. 8. World Health Organization. Availability, Safety, and Quality of Blood Products. 63rd World Health Assembly (WHA 63.12). Geneva, Switzerland: World Health Organization: May, 2010.